Eric Ortman

Eric Ortman currently serves as the Director of Legal Operations at 4D Molecular Therapeutics, a position held since March 2024. Prior to this role, Ortman was the Senior Director of Legal Operations at BeiGene from April 2018 to March 2024 and held similar director-level positions at Ultragenyx Pharmaceutical Inc. and Medivation. Additionally, experience includes consulting roles in healthcare operations and legal operations at various biopharmaceutical companies, including Relypsa and Onyx Pharmaceuticals. Ortman’s educational background includes an MBA from the University of California, Berkeley, and a Bachelor of Science from Cornell University.